The emerging practice of combining kratom, a legal botanical, with opioid medication – often referred to as "Kratom Lean" – presents a complex legal grey area. Currently, the federally regulated status of kratom is in flux, varying significantly by state across localities, while codeine’s control

The combination of kratom and purple drank presents significant regulatory risks for users. While kratom’s status varies regionally, mixing it with codeine, often combined with an antihistamine, can trigger state charges for drug possession. Furthermore, the offering of pre-mixed kratom codeine m

The emergence of novel psychoactive substances is significantly becoming a worry for public health officials . These substances , often distributed as replacements to controlled substances , frequently are missing comprehensive studies regarding their toxicity . Their ease of obtaining online and